CardioSource WorldNews Interventions | Page 36

FELLOWS’ CORNER SANDEEP KUMAR KRISHNAN, MD Fellow-in-Training, University of Washington Medical Center, Seattle, WA Chronic Total Occlusions At the Precipice of a Revolution N othing can be more frustrating to both patients and cardiologists alike than coronary chronic total occlusions (CTOs). CTOs are lesions with Thrombolysis In Myocardial Infarction (TIMI) 0 flow for ≥ 3 months1 and are commonly found in patients undergoing coronary angiography (in 18.4% to 52%).2-5 Due to the technical difficulty of the procedures and their historically low success rates, patients with CTOs are often referred for coronary artery bypass graft surgery (CABG)2,3 but percutaneous coronary intervention (PCI) may be preferred for some, especially those with prior CABG and those with non-left anterior descending single vessel coronary disease.6 Although no randomized controlled clinical trials comparing CTO PCI with medical therapy have been published to date, there is a growing body of evidence suggesting clinical benefits of percutaneous revascularization of CTO. These benefits include an improvement in anginal symptoms,7,8 decreased need for anti-anginal medications, improved exercise capacity,9 improved left ventricular systolic function,10 decreased risk William Lombardi, MD for arrhythmias,11 decreased 12 mortality, and overall improvement in clinical outcomes.13,14 Because CTOs are the most common reason for failing to achieve complete revascularization,15 they are often viewed with apprehension by fellows-in-training (FITS) and practicing interventionalists alike. I recently had an opportunity to sit down with one of the pioneers in the CTO space and a mentor of mine—William Lombardi, MD—to get his thoughts on the field of CTO PCI and why fellows should be interested in the field. Here are some excerpts from my interview with Dr. Lombardi. Dr. Krishnan: Why should fellows learn to treat CTOs? Dr. Lombardi: Historically PCI operators fixed what they could fix. Now that we have learned to treat CTOs with almost 90% success rates without cherry picking; we now have the ability to do 34 CardioSource WorldNews: Interventions complete revascularization for our patients. Along the way, all the knowledge we have gained—how to use a Corsair, the algorithms for impenetrable caps, the algorithms for devices that won’t pass, how to manage guide extensions, how to do use atherectomy outside where it was originally intended—led our profession to a point where we could overcome the historic barriers to complete revascularization including CTO, small vessels, calcification, tortuosity, bifurcations, ostial lesions. It has given us a skill set to allow us to evolve into percutaneous surgeons. The importance to FITs is to change their mindset about how they are being trained. Don’t treat pictures—treat patients. Don’t think about right and wrong ways—discover the algorithms for success. Having that fluid mindset of evolution and creativity and focusing on the real agenda for any intervention—complete revascularization—is the key. How you get there is meaningless—whether a surgeon does it, an interventionalist does it, a surgeon and an interventionalist do it—all the patients and the myocytes know is that they got revascularized. If we focus on that we will get better at our craft. As our skillsets for tackling CTOs grow and we gain the ability to revascularize more complex right coronary artery and left circumflex lesions, will there be a larger role for hybrid coronary procedures (in those patients with triple vessel disease) moving forward? What we are trying to do here at the University of Washington is to do it backwards. The interventionalists start in the hybrid OR by fixing the right and left circumflex coronary arteries and then, on Plavix, the surgeon will put an internal mammary to the left anterior descending. If we don’t get the right or the circumflex fixed, then they [the surgeons] will graft that vessel as well. What we do not want is hybrid procedures to give an inferior result. Historically, the interventional cardiology mindset always pitted PCI as a competitor to surgery, which, in my opinion, was the wrong mindset. Unsurprisingly, PCI lost every time because as the anatomy got harder we did a worse “The importance to the FITs is to challenge their mindset about how they are being trained. Don’t treat pictures—treat patients. Don’t think about right and wrong ways—discover algorithms for success.” —William Lombardi, MD job attaining complete revascularization. There is a litany of data to support this clinical construct. So we have to do something really hard as a profession. Instead of looking at a mirror and patting ourselves on the back and saying “Gosh look how great we are,” we have to ask “Why have we always lost to surgery? Why are we getting incomplete revascularization? Where are the gaps in our training and skill sets? Where are the gaps in our technology?” This will help us focus on what the patient September/October 2016